These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 8637518)

  • 1. The tumor necrosis factor ligand and receptor families.
    Bazzoni F; Beutler B
    N Engl J Med; 1996 Jun; 334(26):1717-25. PubMed ID: 8637518
    [No Abstract]   [Full Text] [Related]  

  • 2. [TNF family (TNF alpha, beta, FasL, CD40L)].
    Manago S; Yonehara S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():202-6. PubMed ID: 15861657
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.
    Heumann D; Le Roy D; Zanetti G; Eugster HP; Ryffel B; Hahne M; Tschopp J; Glauser MP
    J Inflamm; 1995-1996; 47(4):173-9. PubMed ID: 9144074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 8. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease.
    Lynch DH; Campbell KA; Miller RE; Badley AD; Paya CV
    Behring Inst Mitt; 1996 Oct; (97):175-84. PubMed ID: 8950475
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily.
    Gruss HJ
    Int J Clin Lab Res; 1996; 26(3):143-59. PubMed ID: 8905447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disorders.
    Warzocha K; Salles G; Coiffier B
    Acta Haematol Pol; 1995; 26(4):323-32. PubMed ID: 8571733
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lupus nephritis: Pathogenesis, pathophysiology, and therapy].
    Yamada A
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():442-5. PubMed ID: 16523930
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
    Gupta S
    Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Zheng L; Fisher G; Miller RE; Peschon J; Lynch DH; Lenardo MJ
    Nature; 1995 Sep; 377(6547):348-51. PubMed ID: 7566090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin and the release of tumor necrosis factor receptors.
    Jansen J; van der Poll T; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():383-97. PubMed ID: 7831370
    [No Abstract]   [Full Text] [Related]  

  • 18. Is TRAIL hepatotoxic?
    Gores GJ; Kaufmann SH
    Hepatology; 2001 Jul; 34(1):3-6. PubMed ID: 11431726
    [No Abstract]   [Full Text] [Related]  

  • 19. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.